TY - JOUR
T1 - Stem cell-derived extracellular vesicles attenuate the early inflammatory response after tendon injury and repair
AU - Shen, Hua
AU - Yoneda, Susumu
AU - Abu-Amer, Yousef
AU - Guilak, Farshid
AU - Gelberman, Richard H.
N1 - Funding Information:
HS is an inventor with a pending patent that covers the ASC EVs and collagen sheet used in this study. This study is partially supported by the NIH R01 AR062947 and the Foundation for Barnes‐Jewish Hospital. We thank the Washington University Musculoskeletal Research Center (NIH P30 AR057235), Molecular Imaging Center (NIH P50 CA094056), and Wandy Beatty for their respective histology, bioluminiscence imaging, and transmission electron microscopy services. We thank Dr. Stavros Thomopoulos for his helpful feedback during the development of the project and preparation of the manuscript and Dr. Phyllis Hanson for her input on EV biology and technologies.
Funding Information:
HS?is an inventor with a pending patent that covers the ASC EVs and collagen sheet used in this study. This study is partially supported by the NIH R01 AR062947 and the Foundation for Barnes-Jewish Hospital. We thank the Washington University Musculoskeletal Research Center (NIH P30 AR057235), Molecular Imaging Center (NIH P50 CA094056), and Wandy Beatty for their respective histology, bioluminiscence imaging, and transmission electron microscopy services. We thank Dr. Stavros Thomopoulos for his helpful feedback during the development of the project and preparation of the manuscript and Dr. Phyllis Hanson for her input on EV biology and technologies.
Publisher Copyright:
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Adipose-derived stem cells (ASCs) have the potential to enhance tendon repair via paracrine regulation of the inflammatory response to injury. Extracellular vesicles (EVs), which are secreted by ASCs, have shown promise in mediating this process. This study was designed to evaluate the effect of ASC EVs on early tendon healing using a mouse Achilles tendon injury and repair model. EVs were isolated from the conditioned medium of naïve and interferonγ-primed ASCs and applied to the repair site via a collagen sheet. Tendon healing was assessed in nuclear factor-κB (NF-κB)-luciferase reporter mice up to 7 days after suture repair. As anticipated, repair site NF-κB activity increased greater than twofold following tendon repair. Treatment with EVs from primed but not naïve ASCs effectively suppressed the response. Accordingly, the pro-inflammatory genes Il1b and Ifng were both dramatically increased in repaired tendons, while primed, but not naïve ASC EVs attenuated the response. Compared with control repairs, primed ASC EVs further reduced the rate of post-repair tendon gap formation and rupture and facilitated collagen formation at the injury site. Additional experiments demonstrated that EVs target macrophages and that primed ASC EVs were most effective in blocking macrophage NF-κB activity. Collectively, the findings of this study demonstrate that primed ASC EVs, similar to ASCs, attenuate the early tendon inflammatory response after injury via modulation of the macrophage inflammatory response. Statement of clinical significance: These findings introduce a new cell-free therapy, derived from stem cells, for tendon repair with the potential for improved therapeutic efficacy and safety.
AB - Adipose-derived stem cells (ASCs) have the potential to enhance tendon repair via paracrine regulation of the inflammatory response to injury. Extracellular vesicles (EVs), which are secreted by ASCs, have shown promise in mediating this process. This study was designed to evaluate the effect of ASC EVs on early tendon healing using a mouse Achilles tendon injury and repair model. EVs were isolated from the conditioned medium of naïve and interferonγ-primed ASCs and applied to the repair site via a collagen sheet. Tendon healing was assessed in nuclear factor-κB (NF-κB)-luciferase reporter mice up to 7 days after suture repair. As anticipated, repair site NF-κB activity increased greater than twofold following tendon repair. Treatment with EVs from primed but not naïve ASCs effectively suppressed the response. Accordingly, the pro-inflammatory genes Il1b and Ifng were both dramatically increased in repaired tendons, while primed, but not naïve ASC EVs attenuated the response. Compared with control repairs, primed ASC EVs further reduced the rate of post-repair tendon gap formation and rupture and facilitated collagen formation at the injury site. Additional experiments demonstrated that EVs target macrophages and that primed ASC EVs were most effective in blocking macrophage NF-κB activity. Collectively, the findings of this study demonstrate that primed ASC EVs, similar to ASCs, attenuate the early tendon inflammatory response after injury via modulation of the macrophage inflammatory response. Statement of clinical significance: These findings introduce a new cell-free therapy, derived from stem cells, for tendon repair with the potential for improved therapeutic efficacy and safety.
KW - exosome
KW - extracellular vesicle
KW - inflammation
KW - mesenchymal stem cell
KW - tendon injury
UR - http://www.scopus.com/inward/record.url?scp=85070308159&partnerID=8YFLogxK
U2 - 10.1002/jor.24406
DO - 10.1002/jor.24406
M3 - Article
C2 - 31286564
AN - SCOPUS:85070308159
SN - 0736-0266
VL - 38
SP - 117
EP - 127
JO - Journal of Orthopaedic Research
JF - Journal of Orthopaedic Research
IS - 1
ER -